KLK3 and cancer: The use of only a higher PSA cutoff (eg, PSA 5 ng/mL) for risk stratification resulted in delaying more than half of cancer diagnoses, with an individual cancer risk of 11% in unbiopsied men, thus being a less attractive alternative.